Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug companies urged to make more use of UK regulator's ''broader scope'' scientific advice

This article was originally published in SRA

Executive Summary

Pharmaceutical companies in the UK are missing a trick by failing to take advantage of the “broader scope” scientific advice service that is on offer from the Medicines and Healthcare products Regulatory Agency. The UK R&D-based pharma industry association, the ABPI, said in response that it would always encourage companies to get scientific advice from the MHRA and would work with the agency to raise awareness of the scheme within the industry.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS117044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel